Literature DB >> 28495929

Tissue Factor Prothrombotic Activity Is Regulated by Integrin-arf6 Trafficking.

Andrea S Rothmeier1, Patrizia Marchese1, Florian Langer1, Yuichi Kamikubo1, Florence Schaffner1, Joseph Cantor1, Mark H Ginsberg1, Zaverio M Ruggeri1, Wolfram Ruf2.   

Abstract

OBJECTIVE: Coagulation initiation by tissue factor (TF) is regulated by cellular inhibitors, cell surface availability of procoagulant phosphatidylserine, and thiol-disulfide exchange. How these mechanisms contribute to keeping TF in a noncoagulant state and to generating prothrombotic TF remain incompletely understood. APPROACH AND
RESULTS: Here, we study the activation of TF in primary macrophages by a combination of pharmacological, genetic, and biochemical approaches. We demonstrate that primed macrophages effectively control TF cell surface activity by receptor internalization. After cell injury, ATP signals through the purinergic receptor P2rx7 induce release of TF+ microvesicles. TF cell surface availability for release onto microvesicles is regulated by the GTPase arf6 associated with integrin α4β1. Furthermore, microvesicles proteome analysis identifies activation of Gαi2 as a participating factor in the release of microvesicles with prothrombotic activity in flowing blood. ATP not only prevents TF and phosphatidylserine internalization but also induces TF conversion to a conformation with high affinity for its ligand, coagulation factor VII. Although inhibition of dynamin-dependent internalization also exposes outer membrane procoagulant phosphatidylserine, the resulting TF+ microvesicles distinctly lack protein disulfide isomerase and high affinity TF and fail to produce fibrin strands typical for microvesicles generated by thrombo-inflammatory P2rx7 activation.
CONCLUSIONS: These data show that procoagulant phospholipid exposure is not sufficient and that TF affinity maturation is required to generate prothrombotic microvesicles from a variety of cell types. These findings are significant for understanding TF-initiated thrombosis and should be considered in designing functional microvesicles-based diagnostic approaches.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  dynamins; extracellular vesicles; fibrin; macrophages; proteome

Mesh:

Substances:

Year:  2017        PMID: 28495929      PMCID: PMC5501484          DOI: 10.1161/ATVBAHA.117.309315

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  60 in total

1.  The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII.

Authors:  A Rehemtulla; W Ruf; T S Edgington
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

2.  Dynasore, a cell-permeable inhibitor of dynamin.

Authors:  Eric Macia; Marcelo Ehrlich; Ramiro Massol; Emmanuel Boucrot; Christian Brunner; Tomas Kirchhausen
Journal:  Dev Cell       Date:  2006-06       Impact factor: 12.270

3.  Factor VIIa/tissue factor-dependent gene regulation and pro-coagulant activity: effect of factor VIIa concentration.

Authors:  Lars C Petersen; Tatjana Albrektsen; Gertrud M Hjortø; Marianne Kjalke; Søren E Bjørn; Brit B Sørensen
Journal:  Thromb Haemost       Date:  2007-10       Impact factor: 5.249

4.  Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure.

Authors:  Narcis I Popescu; Cristina Lupu; Florea Lupu
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

5.  Mastoparan, a wasp venom, activates platelets via pertussis toxin-sensitive GTP-binding proteins.

Authors:  Y Ozaki; Y Matsumoto; Y Yatomi; M Higashihara; T Kariya; S Kume
Journal:  Biochem Biophys Res Commun       Date:  1990-07-31       Impact factor: 3.575

6.  Heterotrimeric Gα(i) proteins are regulated by lipopolysaccharide and are anti-inflammatory in endotoxemia and polymicrobial sepsis.

Authors:  Hongkuan Fan; Pengfei Li; Basilia Zingarelli; Keith Borg; Perry V Halushka; Lutz Birnbaumer; James A Cook
Journal:  Biochim Biophys Acta       Date:  2011-01-19

7.  Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis.

Authors:  Robert Silasi-Mansat; Hua Zhu; Narcis I Popescu; Glenn Peer; Georgia Sfyroera; Paola Magotti; Lacramioara Ivanciu; Cristina Lupu; Tom E Mollnes; Fletcher B Taylor; Gary Kinasewitz; John D Lambris; Florea Lupu
Journal:  Blood       Date:  2010-05-13       Impact factor: 22.113

8.  Disulfide isomerization switches tissue factor from coagulation to cell signaling.

Authors:  Jasimuddin Ahamed; Henri H Versteeg; Marjolein Kerver; Vivien M Chen; Barbara M Mueller; Philip J Hogg; Wolfram Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-07       Impact factor: 11.205

9.  Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation.

Authors:  Christoph Reinhardt; Marie-Luise von Brühl; Davit Manukyan; Lenka Grahl; Michael Lorenz; Berid Altmann; Silke Dlugai; Sonja Hess; Ildiko Konrad; Lena Orschiedt; Nigel Mackman; Lloyd Ruddock; Steffen Massberg; Bernd Engelmann
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles.

Authors:  Vandhana Muralidharan-Chari; James Clancy; Carolyn Plou; Maryse Romao; Philippe Chavrier; Graca Raposo; Crislyn D'Souza-Schorey
Journal:  Curr Biol       Date:  2009-11-05       Impact factor: 10.834

View more
  22 in total

1.  Acid sphingomyelinase plays a critical role in LPS- and cytokine-induced tissue factor procoagulant activity.

Authors:  Jue Wang; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2019-07-01       Impact factor: 22.113

2.  Protease Activity in Vascular Disease.

Authors:  Megan A Slack; Scott M Gordon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-25       Impact factor: 8.311

3.  The role of type 1 interferons in coagulation induced by gram-negative bacteria.

Authors:  Xinyu Yang; Xiaoye Cheng; Yiting Tang; Xianhui Qiu; Zhongtai Wang; Guang Fu; Jianfeng Wu; Haixia Kang; Jing Wang; Haichao Wang; Fangping Chen; Xianzhong Xiao; Timothy R Billiar; Ben Lu
Journal:  Blood       Date:  2020-04-02       Impact factor: 22.113

4.  Murine tissue factor disulfide mutation causes a bleeding phenotype with sex specific organ pathology and lethality.

Authors:  Susanna H M Sluka; Simon F Stämpfli; Alexander Akhmedov; Tanja Klein-Rodewald; Adrián Sanz-Moreno; Marion Horsch; Paula Grest; Andrea S Rothmeier; Birgit Rathkolb; Anja Schrewe; Johannes Beckers; Frauke Neff; Eckhard Wolf; Giovanni G Camici; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabě de Angelis; Thomas F Lüscher; Wolfram Ruf; Felix C Tanner
Journal:  Haematologica       Date:  2019-09-05       Impact factor: 9.941

Review 5.  Extracellular vesicles in cardiovascular homeostasis and disease.

Authors:  Joshua D Hutcheson; Elena Aikawa
Journal:  Curr Opin Cardiol       Date:  2018-05       Impact factor: 2.161

6.  Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis.

Authors:  Nadine Müller-Calleja; Anne Hollerbach; Svenja Ritter; Denise G Pedrosa; Dennis Strand; Claudine Graf; Christoph Reinhardt; Susanne Strand; Philippe Poncelet; John H Griffin; Karl J Lackner; Wolfram Ruf
Journal:  Blood       Date:  2019-08-21       Impact factor: 22.113

7.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

8.  Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.

Authors:  H M H Spronk; T Padro; J E Siland; J H Prochaska; J Winters; A C van der Wal; J J Posthuma; G Lowe; E d'Alessandro; P Wenzel; D M Coenen; P H Reitsma; W Ruf; R H van Gorp; R R Koenen; T Vajen; N A Alshaikh; A S Wolberg; F L Macrae; N Asquith; J Heemskerk; A Heinzmann; M Moorlag; N Mackman; P van der Meijden; J C M Meijers; M Heestermans; T Renné; S Dólleman; W Chayouâ; R A S Ariëns; C C Baaten; M Nagy; A Kuliopulos; J J Posma; P Harrison; M J Vries; H J G M Crijns; E A M P Dudink; H R Buller; Y M C Henskens; A Själander; S Zwaveling; O Erküner; J W Eikelboom; A Gulpen; F E C M Peeters; J Douxfils; R H Olie; T Baglin; A Leader; U Schotten; B Scaf; H M M van Beusekom; L O Mosnier; L van der Vorm; P Declerck; M Visser; D W J Dippel; V J Strijbis; K Pertiwi; A J Ten Cate-Hoek; H Ten Cate
Journal:  Thromb Haemost       Date:  2018-01-29       Impact factor: 5.249

9.  Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.

Authors:  Andrea S Rothmeier; Enbo Liu; Sagarika Chakrabarty; Jennifer Disse; Barbara M Mueller; Henrik Østergaard; Wolfram Ruf
Journal:  Blood       Date:  2017-12-15       Impact factor: 22.113

Review 10.  Extracellular vesicles in cancer immune responses: roles of purinergic receptors.

Authors:  Michael W Graner
Journal:  Semin Immunopathol       Date:  2018-09-12       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.